platinum has been researched along with Ache in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 6 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balar, A; Campbell, M; Galsky, MD; Heath, EI; Hepp, Z; Mazerolle, F; McGregor, B; McKay, C; O'Donnell, PH; Petrylak, D; Quinn, DI; Regnault, A; Rosenberg, J; Steinberg, J; Yu, EY | 1 |
| Abrams, G; Alfaro, E; Cheung, S; Conley, YP; Cooper, B; Henderson-Sabes, J; Kober, KM; Levine, JD; Miaskowski, C; Paul, SM; Quinn, M; Snowberg, K; Topp, K | 1 |
| Bondarenko, I; Brady, KJS; Chen, CI; Cicin, I; Gogishvili, M; Gullo, G; Gümüş, M; Harnett, J; Ivanescu, C; Kilickap, S; Konidaris, G; Li, S; Mastey, V; Naumann, U; Özgüroğlu, M; Reaney, M; Rietschel, P; Sasane, M; Sezer, A; Turk, HM | 1 |
| Dvorkin, M; Gessner, C; Giorgadze, D; Gogishvili, M; Gullo, G; Ivanescu, C; Kalinka, E; Konidaris, G; Laktionov, K; Makharadze, T; Melkadze, T; Moreno-Jaime, B; Nechaeva, M; Nemsadze, G; Passalacqua, R; Penkov, K; Quek, RGW; Rietschel, P; Rozhkova, I | 1 |
| Chen, M; Chen, MY; Cheng, XP; Cui, WX; Zhang, H | 1 |
| Chen, L; Tang, H; Wang, Y; Yang, N; Zhang, Y | 1 |
| Abrams, G; Chesney, MA; Conley, YP; Cooper, BA; Kober, KM; Levine, JD; Mazor, M; Miaskowski, C; Paul, SM; Schumacher, MA; Topp, K; Wong, ML | 1 |
| Belani, CP; Fidias, P; Fossella, F; Gorbounova, V; Kaukel, E; Mattson, KV; Millward, M; Pereira, JR; Pluzanska, A; Ramlau, R; Szczesna, A; von Pawel, J | 1 |
| Lester, JF; Macbeth, FR | 1 |
| Cooney, DA; Davis, RD; Fleischman, RW; Heyman, IA; Ilievski, V; Phelan, R; Rosenkrantz, H; Schaeppi, U | 1 |
6 trial(s) available for platinum and Ache
| Article | Year |
|---|---|
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
Topics: Adult; Antibodies, Monoclonal; Carcinoma, Transitional Cell; Fatigue; Female; Humans; Immune Checkpoint Inhibitors; Male; Pain; Platinum; Programmed Cell Death 1 Receptor; Quality of Life; Urinary Bladder Neoplasms | 2022 |
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; B7-H1 Antigen; Carcinoma, Non-Small-Cell Lung; Humans; Lung; Lung Neoplasms; Pain; Patient Reported Outcome Measures; Platinum; Quality of Life | 2023 |
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Pain; Patient Reported Outcome Measures; Platinum; Quality of Life | 2023 |
The effect of selenium yeast in the prevention of adverse reactions related to platinum-based combination therapy in patients with malignant tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Neoplasms; Pain; Platinum; Quality of Life; Saccharomyces cerevisiae; Selenium | 2023 |
The efficacy of music therapy to relieve pain, anxiety, and promote sleep quality, in patients with small cell lung cancer receiving platinum-based chemotherapy.
Topics: Anxiety; Humans; Lung Neoplasms; Music Therapy; Pain; Platinum; Sleep; Small Cell Lung Carcinoma | 2021 |
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Patient Compliance; Platinum; Prospective Studies; Psychomotor Performance; Quality of Life; Sickness Impact Profile; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
4 other study(ies) available for platinum and Ache
| Article | Year |
|---|---|
Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
Topics: Antineoplastic Agents; Cancer Survivors; Humans; Neoplasms; Pain; Peripheral Nervous System Diseases; Phenotype; Platinum; Quality of Life; Taxoids | 2022 |
Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Topics: Aged; Antineoplastic Agents; Bridged-Ring Compounds; Cancer Survivors; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Neoplasms; Pain; Patient Reported Outcome Measures; Peripheral Nervous System Diseases; Platinum; Self Report; Surveys and Questionnaires; Taxoids | 2019 |
Quality of life assessment in the TAX 326 study.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Patient Compliance; Platinum; Psychomotor Performance; Quality of Life; Sickness Impact Profile; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.
Topics: Amines; Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Chlorine; Dehydration; Dogs; Haplorhini; Hypoxia; Injections, Intravenous; Lethal Dose 50; Lymphatic Diseases; Mice; Necrosis; Organometallic Compounds; Pain; Platinum; Time Factors; Vomiting | 1973 |